Quick Answer
Oric Pharmaceuticals, Inc. reported Net Income of -$129.47 million for fiscal year 2025.
Oric Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$129.47M | -1.3% |
| 2024 | -$127.85M | -27.0% |
| 2023 | -$100.70M | -13.0% |
| 2022 | -$89.12M | -13.2% |
| 2021 | -$78.72M | -6.8% |
| 2020 | -$73.70M | -174.2% |
| 2019 | -$26.88M | -25.8% |
| 2018 | -$21.36M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.59M | +5.7% | +10.4% |
| June 30, 2025 | -$36.35M | -13.7% | -21.1% |
| March 31, 2025 | -$30.02M | -20.0% | +13.1% |
| September 30, 2024 | -$34.57M | -35.7% | -8.1% |
| June 30, 2024 | -$31.96M | -39.3% | -27.8% |
| March 31, 2024 | -$25.01M | -4.5% | +1.8% |
| September 30, 2023 | -$25.48M | -2.6% | -11.0% |
| June 30, 2023 | -$22.94M | -13.1% | +4.2% |
- Oric Pharmaceuticals, Inc. showed a decrease of -1.3% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Oric Pharmaceuticals, Inc.’s net income has declined by 506.0% (from -$21.36 million to -$129.47 million).
- The most recent figure is from Oric Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: